SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-147812
Filing Date
2011-05-23
Accepted
2011-05-23 16:13:51
Documents
6
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 219971
2 ASSET PURCHASE AGREEMENT dex10122.htm EX-10.122 284786
3 SECTION 302 CERTIFICATION OF CEO dex311.htm EX-31.1 10484
4 SECTION 302 CERTIFICATION OF CFO dex312.htm EX-31.2 10547
5 SECTION 906 CERTIFICATION OF CEO & CFO dex32.htm EX-32 6207
6 GRAPHIC g181942g57p50.jpg GRAPHIC 3721
  Complete submission text file 0001193125-11-147812.txt   538248
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 11865186
SIC: 2834 Pharmaceutical Preparations